Virestone
Media · United States
Member rating: 5.0 (1 review)
A Trust Score is an aggregate of member input and platform signals. It is not a certification, accreditation, or safety rating.
About Virestone
Virestone is an independent, non-commercial reference publisher covering ibogaine evidence, safety and policy in plain language. It describes itself as a resource for readers seeking context rather than a clinic, medical provider or referral service, and states that it does not endorse providers or arrange care. Its main site is ibogaineoverview.com.
Website: https://ibogaineoverview.com
Overview
Virestone is a consumer-facing reference publisher that writes about ibogaine — a psychoactive alkaloid from the West African shrub Tabernanthe iboga — for readers who are trying to understand the substance rather than obtain it. Its material is arranged as explanatory briefs on evidence, safety, regulation and cost, and it states plainly that it is not a clinic, medical provider or referral service. Its primary site is ibogaineoverview.com.
Ibogaine Wiki lists Virestone because its pages circulate widely among people researching the subject, and because its coverage overlaps with the encyclopedic material here. The listing describes how the publisher presents information; it is not an endorsement, and Virestone is treated as a secondary source throughout.
Editorial focus
Virestone publishes reference material for readers trying to understand what ibogaine is, what the published evidence supports and where that evidence remains unsettled — work that overlaps with the encyclopedic coverage on Ibogaine Wiki. Its editors summarize published research, registry entries and official records rather than producing primary research of their own.
Its stated purpose is to organize information for people seeking context on ibogaine research, safety concerns, regulation and open questions, and it says explicitly that it does not direct anyone toward treatment or use. Material is arranged as a chronological brief alongside risk-focused and research-focused pages, so that differences in source quality are easier to see.
Subjects covered
The publisher's pages cluster around a small number of recurring subjects:
- Pharmacology and metabolism, including the long-lived metabolite noribogaine
- Reported effects on opioid withdrawal and dependence, and the limits of that evidence
- Cardiac risk, QT prolongation and the case for monitored settings
- Legal status across jurisdictions, and how it changes over time
- Treatment cost and why published figures vary so widely
- Traditional and ceremonial use in Gabon and neighboring countries, including Bwiti practice
Editorial approach
Virestone describes four operating principles: independence, safety first, evidence over hype and plain language. It draws on published literature, trial registries such as ClinicalTrials.gov, and official regulatory material rather than informal summaries, and it presents findings in proportion to their limits — small samples, shifting terminology, publication gaps and differences between jurisdictions.
On safety, the publisher frames discussion around cardiac risk and the need for qualified medical supervision, and points readers to official drug-safety information rather than offering treatment instructions. On legal status, it distinguishes advocacy and research from legal authority and stresses checking the date of any claim.
Sourcing and dating of claims
Because the field moves through preprints, conference abstracts, observational series and press coverage before it reaches controlled trials, Virestone's pages tend to attach dates and jurisdictions to claims rather than stating them flatly. Readers comparing its summaries with the underlying literature should still check publication dates, sample sizes and whether a cited result comes from a controlled trial or an uncontrolled series.
Independence and limits
Virestone states that it is not a clinic, medical provider or referral service, does not endorse providers, and does not verify promotional claims made elsewhere. It also cautions that cost figures vary widely by setting and jurisdiction and should not be read as clinical, legal or financial guidance.
Because it is a secondary publisher, Ibogaine Wiki treats Virestone as context for how ibogaine information is presented to the public, not as a primary source for clinical or regulatory claims. Statements that matter clinically should be traced to the underlying research or official record.
How this listing is maintained
Directory listings on Ibogaine Wiki record what an organization says about itself, what can be verified independently, and which contributors have disclosed a connection to it. Claims that cannot be confirmed from a primary or official record are either attributed to the organization or left out. Anyone with a connection to Virestone can claim this listing and correct the description and website; disclosed connections are shown below, and editorial control of the surrounding wiki text stays with Ibogaine Wiki contributors.
Related sites
Several other consumer-facing ibogaine websites are sometimes associated with Virestone, including bestibogainetreatmentcenters.com, costofibogainetreatment.com, ibogainecardiacrisk.com and bajaibogainetreatment.com. These carry separate branding or none at all — ibogainelegalstatus.com, for example, is published under the name Juravine — so their ownership is not independently confirmed here and they are listed only as context.
Websites operated by Virestone
These sites are properties of Virestone, not independent sources.
Independent Sources
Reference sources used in our editorial work.
Editors Connected to This Organization
- Nafi Siam — Owner, Operator
Disclosure
Disclosure: this organization is connected to the operators of Ibogaine Wiki.
Rating
Ratings and written reviews left by members about Virestone, out of 5 stars. Reviews are a separate system from site standing, which members earn from their own contributions.
Loading reviews…